Skip to main content
Press release May 13, 2026

Lantern Pharma Inc. Announces up to $9.25 Million Registered Direct Offering with Existing Holders and a Single Institutional Investor

Lantern Pharma Inc. (LTRN)

We couldn't retrieve the full text for this release. Read it on the company's site.

Read full release on company site